本页面由Tiger Trade Technology Pte. Ltd.提供服务

Repare Therapeutics Inc.

2.65
0.0000
成交量:- -
成交额:321.86万
市值:1.14亿
市盈率:-1.56
高:2.65
开:2.65
低:2.65
收:2.65
52周最高:2.66
52周最低:0.8900
股本:4,310.84万
流通股本:2,271.52万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.6944
每股收益(LYR):-1.9969
净资产收益率:-49.78%
总资产收益率:-29.72%
市净率:0.99
市盈率(LYR):-1.33

数据加载中...

2026/01/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/01/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/01/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/01/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/01/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/01/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/01/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/01/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/01/28

重要事件披露

Form 8-K - Current report
2026/01/28

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2026/01/16

重要事件披露

Form 8-K - Current report
2025/12/29

重要事件披露

Form 8-K - Current report
2025/12/19

重要事件披露

Form 8-K - Current report
2025/11/17

重要事件披露

Form 8-K - Current report
2025/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/14

重要事件披露

Form 8-K - Current report
2025/10/22

重要事件披露

Form 8-K - Current report
2025/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/08

重要事件披露

Form 8-K - Current report
2025/07/16

重要事件披露

Form 8-K - Current report